Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TearLab Corp - Ordinary Shares TEAR

Healthcare Diagnostics & Research
TearLab Corp is a part of the diagnostic industry. It is an in-vitro diagnostic company based in the United States. TearLab has commercialized a proprietary tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The company operates through its wholly-owned... see more

Recent & Breaking News (GREY:TEAR)

GW Pharmaceuticals to Present at the Bank of America Merrill Lynch 2016 Healthcare Conference on 10 May

GlobeNewswire May 4, 2016

SoldierStrong to Donate Ekso GT™ Robotic Exoskeleton for Use with Stroke and Spinal Cord Injury Patients

GlobeNewswire May 4, 2016

TearLab to Release First Quarter 2016 Financial Results on May 4, 2016  - Conference Call to Follow

GlobeNewswire April 25, 2016

TearLab Announces First Quarter 2016 Preliminary Financial Estimates

GlobeNewswire April 20, 2016

TearLab to Participate in the 28th Annual ROTH Conference

GlobeNewswire March 10, 2016

TearLab Reports Fourth Quarter and Full Year 2015 Financial Results

GlobeNewswire March 8, 2016

TearLab Announces Strategic Restructuring

GlobeNewswire February 29, 2016

TearLab to Release Fourth Quarter and Full Year 2015 Financial Results on March 8, 2016 - Conference Call to Follow

GlobeNewswire February 19, 2016

TearLab Announces Withdrawal of Proposed Public Offering of Common Stock

GlobeNewswire February 9, 2016

TearLab Announces Proposed Public Offering of Common Stock

GlobeNewswire February 1, 2016

TearLab Announces Fourth Quarter 2015 Preliminary Financial Estimates and Provides Corporate Update

GlobeNewswire February 1, 2016

TearLab Corporation Reports Q3-15 Financial Results

GlobeNewswire November 5, 2015

TearLab to Participate in November Investor Conferences

GlobeNewswire November 4, 2015

TearLab Corporation to Release Q3 2015 Financial Results on November 5, 2015

GlobeNewswire October 19, 2015

Medical Necessity of Tear Osmolarity Testing in the Diagnosis and Management of Dry Eye Disease Confirmed in Recently Published Medicare Local Coverage Determination

GlobeNewswire October 9, 2015

TearLab to Participate in Craig-Hallum's 6th Annual Alpha Select Conference

GlobeNewswire September 10, 2015

TearLab Corporation Reports Q2-15 Financial Results

GlobeNewswire August 6, 2015

TearLab Corporation to Release Q2 2015 Financial Results on August 6, 2015

GlobeNewswire July 20, 2015

TearLab Corporation to Release Q2 2015 Financial Results on August 6, 2015

GlobeNewswire July 20, 2015

TearLab Announces Appointment of Wes Brazell as CFO

GlobeNewswire July 6, 2015